GMO Research & AI,Inc. (3695) AI Stock Analysis

• Market Cap: ¥7.48B
• Dividend Yield: 5.22%
• Average Volume (3M): 4.97K
• Price to Earnings (P/E): 51.1
• Beta (1Y): 0.39
• Revenue Growth: 26.41%
• EPS Growth: -20.60%
• Country: JP
• Employees: 135
• Sector: Technology
• Sector Strength: 88
• Industry: Specialty Business Services
• EPS (TTM): 14.35
• Shares Outstanding: 4,446,357
• 10 Day Avg. Volume: 4,400
• 30 Day Avg. Volume: 4,966
• PEG Ratio: -0.81
• Price to Book (P/B): 3.27
• Price to Sales (P/S): 1.17
• P/FCF Ratio: 8.06
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: N/A
• Price Target Upside: N/A
• Rating Consensus: N/A
• Number of Analyst Covering: 0
• EPS Forecast (FY): N/A
• Revenue Forecast (FY): N/A

• Rating: 59 Neutral
• Price Target: ¥1,802.00 ▼(-9.04% Downside)
• Action: Reiterated Date: 02/18/26
• Date: Action: Reiterated 02/18/26

The score is primarily supported by improving financial performance—strong 2025 revenue recovery, higher gross margin, and a sharp improvement in free cash flow. This is tempered by clear technical weakness (bearish trend and negative momentum signals) and a demanding valuation (high P/E), with added risk from the 2025 increase in leverage alongside compressed net margins.

Positive Factors

Revenue Recovery

A clear revenue rebound in 2025 (~+19% YoY) indicates regained demand or successful commercial execution. Sustained top-line recovery improves scale economics, funds reinvestment, and reduces execution risk over the medium term if the company sustains this growth trajectory.

Negative Factors

Compressed Net Margin

Net margin compression to ~2.3% significantly reduces earnings cushion versus prior years. Persistently low net margins make the firm more vulnerable to cost shocks, limit retained earnings for reinvestment, and strain long-term return on capital unless operating efficiencies or pricing improvements continue.

GMO Research & AI,Inc. Business Overview & Revenue Model

Company Description

GMO Research & AI, Inc. provides an audience engagement platform in Japan and internationally. The company's audience engagement platform provides access to Asia Cloud Panel, a multi-panel and multi-country online panel network. The company provid...

Read more

GMO Research & AI, Inc. provides an audience engagement platform in Japan and internationally. The company's audience engagement platform provides access to Asia Cloud Panel, a multi-panel and multi-country online panel network. The company provid...

How the Company Makes Money

GMO Research & AI generates revenue through multiple streams, primarily by offering subscription-based access to its AI-driven research platforms and analytics tools. Additionally, the company earns money by providing customized market research se...

Read more

GMO Research & AI generates revenue through multiple streams, primarily by offering subscription-based access to its AI-driven research platforms and analytics tools. Additionally, the company earns money by providing customized market research se...

GMO Research & AI,Inc. Financial Statement Overview

Breakdown	TTM	Dec 2025	Dec 2024	Dec 2023	Dec 2022	Dec 2021
Income Statement
Total Revenue	5.73B	6.82B	5.03B	5.12B	5.20B	4.09B
Gross Profit	3.12B	3.83B	2.55B	2.54B	2.46B	1.98B
EBITDA	388.95M	489.82M	340.09M	529.91M	505.32M	421.41M
Net Income	99.47M	155.64M	183.15M	307.31M	356.38M	274.06M
Balance Sheet
Total Assets	3.84B	9.46B	3.01B	2.99B	3.07B	2.80B
Cash, Cash Equivalents and Short-Term Investments	1.68B	5.52B	1.19B	1.33B	1.17B	1.26B
Total Debt	4.56M	650.22M	5.50M	12.22M	16.80M	19.29M
Total Liabilities	1.58B	7.00B	892.65M	946.14M	1.16B	1.12B
Stockholders Equity	2.24B	2.43B	2.10B	2.05B	1.91B	1.68B
Cash Flow
Free Cash Flow	0.00	986.28M	236.43M	474.82M	128.69M	472.10M
Operating Cash Flow	0.00	990.78M	237.50M	475.49M	131.65M	482.16M
Investing Cash Flow	0.00	-379.84M	-221.00M	-131.49M	-111.34M	-50.65M
Financing Cash Flow	0.00	455.83M	-195.90M	-187.50M	-145.31M	-96.53M

GMO Research & AI,Inc. Technical Analysis

• Technical Analysis Sentiment: Negative
• Last Price: 1981.00
• 50DMA: Negative
• 100DMA: Negative
• 200DMA: Negative
• MACD: Negative
• RSI: Neutral
• STOCH: Positive

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:3695, the sentiment is Negative. The current price of 1981 is above the 20-day moving average (MA) of 1745.30, above the 50-day MA of 1865.06, and below the 200-day MA of 2131.92, indicating a bearish trend. The MACD of -36.46 indicates Negative momentum. The RSI at 37.79 is Neutral, neither overbought nor oversold. The STOCH value of 10.54 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for JP:3695.

GMO Research & AI,Inc. Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
4171	72 Outperform	¥3.97B	17.90	―	4.27%	-3.62%	-17.47%
6088	71 Outperform	¥53.55B	17.17	―	2.56%	8.08%	10.43%
4346	64 Neutral	¥9.34B	35.99	―	3.65%	16.07%	50.91%
6183	64 Neutral	¥102.84B	11.39	―	4.17%	0.44%	44.52%
Sector *	61 Neutral	$37.18B	12.37	-10.20%	1.83%	8.50%	-7.62%
3695	59 Neutral	¥7.48B	51.08	―	5.22%	26.41%	-20.60%
7814	52 Neutral	¥28.06B	5.57	―	1.57%	9.04%	-0.91%